Guggenheim Downgrades NUVL to Hold with $124 Price Target
Guggenheim has lowered its rating on NUVL to hold, setting a new price target of $124, a 0.61% upside from the current price.
Key Points
- Guggenheim downgraded NUVL to a hold rating, setting a new price target of $124 on June 10, 2026.
- Guggenheim's $124 price target implies 0.61% upside from Nuvalent Inc's ($NUVL) current $123.25 share price.
- NUVL shares are trading at $123.25, with significant insider selling activity reported in early June.
- Institutional investors like JPMorgan Chase & Co increased their NUVL holdings by 883,098 shares, reaching a total of 3,088,349 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 10, 2026, Guggenheim downgraded its rating on NUVL to hold, assigning a new price target of $124. This move comes as NUVL shares trade around $123.25, reflecting the latest sentiment shift among analysts.
Other Institutional Activity in NUVL
Several institutional investors have been adjusting their positions in NUVL. Deerfield Management Company maintained its holdings at 17,248,450 shares, valued at about $1.77 billion. FMR LLC reduced its stake by 1,577,925 shares, now holding 9,274,959 shares worth approximately $950.2 million. Paradigm Biocapital Advisors LP added 55,000 shares, bringing its total to 5,324,433 shares, valued at around $545.5 million. BlackRock, Inc. increased its position by 19,524 shares, ending with 4,824,785 shares worth about $494.3 million. Meanwhile, JPMorgan Chase & Co saw a significant increase, adding 883,098 shares to reach 3,088,349 shares, valued at roughly $298.7 million.
Insider Buying and Selling at Nuvalent Inc
Recent insider transactions at NUVL show notable activity. On June 9, 2026, Chief Development Officer Darlene Noci sold 20,000 shares at an average price of $122.81, with part of the sale planned. On the same date, Noci also purchased 20,000 shares at $9.59. President and CEO James Richard Porter sold 30,000 shares on June 8, 2026, at an average price of $88.53, with part of this sale planned as well. Porter also bought 30,000 shares at $18.93 on the same day.
Analysts Set New Price Targets
On June 10, 2026, several analysts, including TD Cowen, Barclays, UBS, and Guggenheim, downgraded NUVL to a hold rating, each setting a price target of $124. Wells Fargo, HC Wainwright & Co., Wedbush, and LifeSci Capital also downgraded the stock on June 9, 2026, to a hold with the same target price. The consensus across the board reflects a cautious stance, with a target mean price of $124 based on multiple analyst opinions.
Bottom Line
Guggenheim's downgrade of NUVL to a hold with a $124 price target highlights a shift in analyst sentiment. Investors are closely watching insider and institutional activities for further clues. As always, these ratings are backward-looking and might not reflect current market conditions.
Get Nuvalent Inc alerts
New 13F filings, insider trades, and analyst moves on $NUVL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.